Dermatopathology of skin cancer in solid organ transplant recipients

Transplantation Reviews

Volumn 24, Issue 4, 2010, Pages 172-189

  Stoff, Benjamin ^a   Salisbury, Catherine ^a   Parker, Douglas ^b   O'Reilly Zwald, Fiona ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ALPHA INTERFERON; ANTHRACYCLINE; AZATHIOPRINE; BLEOMYCIN; CARBOPLATIN; CISPLATIN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; GANCICLOVIR; IMIQUIMOD; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 2; PSORALEN; RAPAMYCIN; RETINOID; RITUXIMAB; VINCRISTINE;

ACTINIC KERATOSIS; BASAL CELL CARCINOMA; CANCER COMBINATION CHEMOTHERAPY; CANCER INCIDENCE; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RISK; CHEMOSURGERY; CLINICAL FEATURE; CRYOSURGERY; CURETTAGE; CYTOREDUCTIVE SURGERY; DESICCATION; ELECTRODESSICATION; EXCISION; GRAFT RECIPIENT; HEART TRANSPLANTATION; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; HUMAN HERPESVIRUS 8; IMMUNOSUPPRESSIVE TREATMENT; KAPOSI SARCOMA; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LYMPH NODE BIOPSY; LYMPHOPROLIFERATIVE DISEASE; MELANOMA; MERKEL CELL TUMOR; ORGAN TRANSPLANTATION; PHOTODYNAMIC THERAPY; POROKERATOSIS; POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDER; PREVALENCE; REVIEW; SKIN BIOPSY; SKIN CANCER; SKIN CARCINOGENESIS; SKIN CARCINOMA; SKIN EXAMINATION; SKIN MANIFESTATION; SOLID ORGAN TRANSPLANTATION; SQUAMOUS CELL CARCINOMA; VIRUS CARCINOGENESIS;

EID: 77956995578     PISSN: 0955470X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trre.2010.05.002     Document Type: Review

References (107)

1. Cockerell C.J. Histopathology of incipient squamous cell carcinoma ("actinic keratosis"). J Am Acad Dermatol 2000, 42:11-17.
2. Rowert-Huber J., Patel M.J., Forschner T., et al. Actinic keratosis is an early in situ squamous cell carcinoma: a proposal for reclassification. Br J Dermatol 2007, 156(s3):8-12.
3. Marks R., Rennie G., Selwood T.S. Malignant transformation of solar keratoses to squamous cell carcinoma. Lancet 1988, 1:795-797.
4. Vasiljevic N., Hazard K., Dillner J., Forslund O. Four novel human betapapillomaviruses of species 2 preferentially found in actinic keratosis. J Gen Virol 2008, 89:2467-2474.
5. Leffell D.J. The scientific basis of skin cancer. J Am Acad Dermatol 2000, 42:18-22.
6. Salasche S.J. Epidemiology of actinic keratoses and squamous cell carcinoma. J Am Acad Dermatol 2000, 42:4-7.
7. Criscione V.D., Weinstock M.A., Naylor M.F., Luque C., Elde M.J., Bingham S.F. Actinic keratosis: natural history and risk of malignant transformation in the Veterans Affairs Topical Tretinoin Chemoprevention Trial. Cancer 2009, 115:2523-2530.
8. Euvrard S., Kanitakis J., Pouteil-Noble C., et al. Comparative epidemiologic study of premalignant and malignant epithelial cutaneous lesions developing after kidney and heart transplantation. J Am Acad Dermatol 1995, 33:222-229.
9. Moy R.L. Clinical presentation of actinic keratoses and squamous cell carcinoma. J Am Acad Dermatol 2000, 42:8-10.
10. Ulrich C., Kanitakis J., Stockfleth E., Euvrard S. Skin cancer in organ transplant recipients-where do we stand today?. Am J Transplant 2008, 8:2192-2198.
11. Boyd A.S., Stasko T., Cameron G.S., Russell M., King L.E. Histologic features of actinic keratosis in solid organ transplant recipients and healthy controls. J Am Acad Dermatol 2001, 45:217-221.
12. Ulrich C. Topical treatment of field cancerization. Cancer Treat Res 2009, 146:439-446.
13. Ulrich C., Busch J.O., Meyer T., et al. Successful treatment of multiple actinic keratoses in organ transplant patients with topical 5% imiquimod: a report of six cases. Br J Dermatol 2006, 155:451-454.
14. Perrett C.M., McGregor J.M., Warwick J., et al. Treatment of post-transplant premalignant skin disease: a randomized intrapatient comparative study of 5-fluorouracil cream and topical photodynamic therapy. Br J Dermatol 2007, 156:320-328.
15. Proby C., Harwood C. Porokeratosis in organ transplantation recipients. Skin disease in organ transplantation 2008, 119-121. Cambridge University Press, New York. C.C. Otley, T. Stasko (Eds.).
16. Kovach B.T., Stasko T. Use of topical immunomodulators in organ transplant recipients. Dermatol Ther 2005, 18:19-27.
17. Brown V.L., Atkins C.L., Ghali L., Cerio R., Harwood C.A., Proby C.M. Safety and efficacy of 5% imiquimod cream for the treatment of skin dysplasia in high-risk renal transplant recipients: randomized, double-blind, placebo-controlled trial. Arch Dermatol 2005, 141:985-993.
18. de Graaf Y.G., Basdew V.R., van Zwan-Kralt N., Willemze R., Bavnick J.N. The occurrence of residual or recurrent squamous cell carcinomas in organ transplant recipients after curettage and electrodessication. Br J Dermatol 2006, 154:493-497.
19. Stasko T., Brown M.D., Carucci J.A., et al. Guidelines for the management of squamous cell carcinoma in organ transplant recipients. Dermatol Surg 2004, 30:642-650.
20. George R., Weightman W., Russ G.R., Bannister K.M., Mathew T.H. Acitretin for chemoprevention of non-melanoma skin cancers in renal transplant recipients. Australas J Dermatol 2002, 43:269-273.
21. Leibovitch I., Huilgol S.C., Selva D., Hill D., Richards S., Paver R. Cutaneous squamous cell carcinoma treated with Mohs micrographic surgery in Australia I. Experience over 10 years. J Am Acad Dermatol 2005, 53:253-260.
22. Telfer N.R., Colver G.B., Morton C.A. Guidelines for the management of basal cell carcinoma. Br J Dermatol 2008, 159:35-48.
23. Tsao H., Atkins M.B., Sober A.J. Management of cutaneous melanoma. N Engl J Med 2004, 351:998-1012.
24. Schwartz R.A., Micali G., Nasca M.R., Scuderi L. Kaposi sarcoma: a continuing conundrum. J Am Acad Dermatol 2008, 59:179-206.
25. Antman K., Change Y. Kaposi's sarcoma. N Engl J Med 2000, 342:1027-1038.
26. Merkel cell carcinoma: recent progress and current priorities on etiology, pathogenesis, and clinical management. J Clin Oncol 2009, 27:4021-4026. Rockville Merkel Cell Carcinoma Group.
27. Poulsen M. Merkel-cell carcinoma of the skin. Lancet Oncol 2004, 5:593-599.
28. Andreone P., Gramenzi A., Lorenzini S., et al. Posttransplantation lymphoproliferative disorders. Arch Intern Med 2003, 163:1997-2004.
29. Weber S., Green M. Posttransplantation lymphoproliferative disorders. Pediatr Clin North Am 2003, 50:1471-1479.
30. Reed R.J., Leone P. Porokeratosis-a mutant clonal keratosis of the epidermis. I. Histogenesis. Arch Dermatol 1970, 101:340-347.
31. Otsuka F., Chi H.I., Shima A., Ishibashi Y. Cytological demonstration of abnormal DNA ploidy in the epidermis of porokeratosis. Arch Dermatol Res 1988, 280:61-63.
32. Herranz P., Pizarro A., De Lucas R., et al. High incidence of porokeratosis in renal transplant recipients. Br J Dermatol 1997, 136:176-179.
33. Silver S.G., Crawford R.I. Fatal squamous cell carcinoma arising from transplant-associated porokeratosis. J Am Acad Dermatol 2003, 49:931-933.
34. Schamroth J.M., Zlotogorski A., Gilead L. Porokertosis of Mibelli. Overview and review of the literature. Acta Derm Venereol 1997, 77:207-213.
35. Perez-Crespo M., Betlloch I., Lucas-Costa A., Banuis-Roca J., Niviero de Jaime M., Mataix J. Unusual evolution of giant porokeratosis developing in two renal transplant patients. Int J Dermatol 2008, 47:759-760.
36. Leache A., Soto de Delas J., Vazques Doval J., Lozano M.D., Quintanilla E. Squamous cell carcinoma arising from a lesion of disseminated superficial actinic porokeratosis. Clin Exp Dermatol 1991, 16:460-462.
37. Lorenz G.E., Ritter S.E. Linear porokeratosis: a case report and review of the literature. Cutis 2008, 81:479-483.
38. Tourand J.P., Dalac S., Collet E., et al. Punctate porokeratosis in a renal transplant recipient. Clin Exp Dermatol 2003, 28:329-330.
39. Marschalko M., Somlai B. Porokeratosis plantaris, palmaris, et disseminata. Arch Dermatol 1986, 122:890-891.
40. Sasson M., Krain A.D. Porokeratosis and cutaneous malignancy. A review. Dermatol Surg 1996, 22:339-342.
41. Jurecka W., Neumann R.A., Knobler R.M. Porokeratoses: immunohistochemical, light and electron microscopic evaluation. J Am Acad Dermatol 1991, 24:96-101.
42. Piepkorn M.W. Alterations of the stratum corneum and epidermis. Textbook of dermatopathology 2004, 344. McGraw Hill, New York. 2nd ed. R.L. Barnhill, A.N. Crowson (Eds.).
43. Alam M., Ratner D. Cutaneous squamous cell carcinoma. N Engl J Med 2001, 344:975-983.
44. Kraemer K.H., Lee M.M., Scotto J. Xeroderma pigmentosum. Cutaneous, ocular, and neurologic abnormalities in 830 published cases. Arch Dermol 1987, 123:241-250.
45. Dubina M., Goldenberg G. Viral-associated nonmelanoma skin cancers: a review. Am J Dermatopathol 2009, 31:561-573.
46. Wong S.S., Tan K.C., Goh C.L. Cutaneous manifestations of chronic arsenicism: review of seventeen cases. J Am Acad Dermatol 1998, 38:179-185.
47. Hensel K.S., Ono C.M., Doukas W.C. Squamous cell carcinoma in chronic ulcerative lesions: a case report and literature review. Am J Orthop 1999, 28:253-256.
48. Diepgen T.L., Mahler V. The epidemiology of skin cancer. Br J Dermatol 2002, 146(Suppl 61):1-6.
49. Euvrard S., Kanitakis J., Claudy A. Skin cancers after organ transplantation. N Engl J Med 2003, 348:1681-1691.
50. Wu J.J., Orengo I.F. Squamous cell carcinoma in solid-organ transplantation. Dermatol Online J 2002, 8:4.
51. Bouwes Bavnick J.N., Hardie D.R., Green A., et al. The risk of skin cancer in renal transplant recipients in Queensland, Australia. A follow-up study. Transplantation 1996, 61:715-721.
52. Lindelof B. The epidemiology of skin cancer in organ transplant recipients. Skin disease in organ transplantation 2008, 142-146. Cambridge University Press, New York. C.C. Otley, T. Stasko (Eds.).
53. Ho W.L., Murphy G.M. Update on the pathogenesis of post-transplant skin cancer in renal transplant recipients. Br J Dermatol 2008, 158:217-224.
54. Lohmann C.M., Solomon A.R. Clinicopathologic variants of cutaneous squamous cell carcinoma. Adv Anat Pathol 2001, 8:27-36.
55. Jensen P., Hansen S., Moller B., et al. Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens. J Am Acad Dermatol 1999, 40:177-186.
56. Brewer J.D., Colegio O.R., Phillips P.K., et al. Incidence of and risk factors for skin cancer after heart transplant. Arch Dermatol 2009, 145:1391-1396.
57. Ingvar A., Smedby K.D., Lindelof B., et al. Immunosuppressive treatment after solid organ transplantation and risk of post-transplant cutaneous squamous cell carcinoma. Nephrol Dial Transplant 2009, 1-8. [Epub ahead of print].
58. Otley C.C., Berg D., Ulrich C., et al. Reduction of immunosuppression for transplant associated skin cancer: expert consensus survey. Br J Dermatol 2006, 154:395-400.
59. Cassarino D.S., Derienzo D.P., Barr R.J. Cutaneous squamous cell carcinoma: a comprehensive clinicopathologic classification. Part one. J Cutan Pathol 2006, 33:191-206.
60. Cassarino D.S., Derienzo D.P., Barr R.J. Cutaneous squamous cell carcinoma: a comprehensive clinicopathologic classification. Part two. J Cutan Pathol 2006, 33:261-279.
61. Rowe D.E., Carroll R.J., Day C.L. Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. Implications for treatment modality selection. J Am Acad Dermatol 1992, 26:976-990.
62. Brantsch K.D., Meisner C., Schonfisch B., et al. Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study. Lancet Oncol 2008, 9:713-720.
63. Ong C.S., Keogh A.M., Kossard S., Macdonald P.S., Spratt P.M. Skin cancer in Australian heart transplant recipients. J Am Acad Dermatol 1999, 40:27-34.
64. Smith K.J., Hamza S., Skelton H. Histologic features in primary cutaneous squamous cell carcinomas in immunocompromised patients focusing on organ transplant patients. Dermatol Surg 2004, 30:634-641.
65. Harwood C.A., Proby C.M., McGregor J.M., Sheaff M.T., Leigh I.M., Cerio R. Clinicopathologic features of skin cancer in organ transplant recipients: a retrospective case-control series. J Am Acad Dermatol 2006, 54:290-300.
66. Seukeran D.C., Newstead C.G., Cunliffe W.J. The compliance of renal transplant recipients with advice about sun protection measures. Br J Dermatol 1998, 138:301-303.
67. Ulrich C., Jurgensen J.S., Degen A., et al. Prevention of non-melanoma skin cancer in organ transplant recipients by regular use of a sunscreen: a 24 months, prospective, case-control study. Br J Dermatol 2009, 161:78-84.
68. Reichrath J., Nurnberg B. Solar UV-radiation, vitamin D and skin cancer surveillance in organ transplant recipients (OTRs). Adv Exp Med Biol 2008, 624:203-214.
69. Rubin A.I., Chen E.H., Ratner D. Basal-cell carcinoma. N Engl J Med 2005, 353:2262-2269.
70. Dlugosz A.A., Talpaz M. Following the hedgehog to new cancer therapies. N Engl J Med 2009, 361:1202-1205.
71. Von Hoff D.D., LoRusso P.M., Rudin C.M., et al. Inhibition of hedgehog pathway in advanced basal-cell carcinoma. N Engl J Med 2009, 361:1164-1172.
72. Crowson A.N. Basal cell carcinoma: biology, morphology, and clinical implications. Mod Pathol 2006, 19(Suppl 2):S127-S147.
73. Moloney F.J., Comber H., O'Lorcain P., O'Kelly P., Conlon P.J., Murphy G.M. A population-based study of skin cancer incidence and prevalence in renal transplant recipients. Br J Dermatol 2006, 154:489-504.
74. Perera G.K., Child F.J., Heaton N., O'Grady J., Higgins E.M. Skin lesions in adult liver transplant recipients: a study of 100 consecutive patients. Br J Dermatol 2006, 154:868-872.
75. Snow S.N., Sahl W., Lo J.S., et al. Metastatic basal cell carcinoma. Report of five cases. Cancer 1994, 73:328-335.
76. Rapini R.P. Practical dermatopathology 2005, Elsevier Mosby, Philadelphia (Pa).
77. Sexton M., Jones D.B., Maloney M.E. Histologic pattern analysis of basal cell carcinoma. study of a series of 1039 consecutive neoplasms. J Amer Acad Dermatol 1990, 23:1118-1126.
78. Kanitakis J., Alhaj-Ibrahim L., Euvrard S., Claudy A. Basal cell carcinomas developing in solid organ transplant recipients: clinicopathologic study of 176 cases. Arch Dermatol 2003, 139:1133-1137.
79. Miller A.J., Mihm M.C. Melanoma. N Engl J Med 2006, 355:51-65.
80. Altekruse SF, Kosary CL, Krapcho M, Neyman N, Aminou R, Waldron W, et al. (eds). SEER Cancer Statistics Review, 1975-2007, National Cancer Institute. Bethesda, MD, based on November 2009 SEER data submission, posted to the SEER web site, 2010, accessed January 2010. http://seer.cancer.gov/csr/1975_2007/.
81. Markovic S.N., Erickson L.A., Rao R.D., et al. Malignant melanoma in the 21st century, part 1: epidemiology, risk factors, screening, prevention, and diagnosis. Mayo Clin Proc 2007, 82:364-380.
82. Curtin J.A., Busam K., Pinkel D., Bastian B.C. Somatic activation of KIT in distinct subtypes of melanoma. J Clin Oncol 2006, 24:4340-4346.
83. Hollenbeak C.S., Todd M.M., Billingsley E.M., Harper G., Dyer A.M., Lengerich E.J. Increased incidence of melanoma in renal transplant recipients. Cancer 2005, 104:1962-1967.
84. Zwald F.O., Chistenson L.J., Billingsley E.M., et al. Melanoma in solid organ transplant recipients. Am J Transplant 2010, 10:1297-1304.
85. Christenson L.J. Malignant melanoma in organ transplant recipients. Skin disease in organ transplantation 2008, 182-189. Cambridge University Press, New York. C.C. Otley, T. Stasko (Eds.).
86. Kasiske B.L., Snyder J.J., Gilbertson D.T., Wang C. Cancer after kidney transplantation in the United States. Am J Transplant 2004, 4:905-913.
87. Penn I. Malignant melanoma in organ allograft recipients. Transplantation 1996, 61:274-278.
88. Le Mire L., Hollowood K., Gray D., Bordea C., Wojnarowski F. Melanomas in renal transplant recipients. Br J Dermatol 2006, 154:472-477.
89. Liu V., Mihm M.C. Pathology of malignant melanoma. Surg Clin North Am 2003, 83:31-60.
90. Barnhill R.L. Tumors of melanocytes. Textbook of dermatopathology 2004, 635-709. McGraw Hill, New York. 2nd ed. R.L. Barnhill, A.N. Crowson (Eds.).
91. Balch C.M., Gershenwald J.E., Soong S.J., et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol 2009, 27:6199-6206.
92. Morton D.L., Thompson J.F., Cochran A.J., et al. Sentinel node biopsy or nodal observation in melanoma. N Engl J Med 2006, 355:1307-1317.
93. Thirlwell C., Nathan P. Melanoma-part 2: management. BMJ 2008, 337:a2488.
94. Euvrard S., Kanitakis J. Kaposi sarcoma in organ transplant recipients. Skin disease in organ transplantation 2008, 195-198. Cambridge University Press, New York. C.C. Otley, T. Stasko (Eds.).
95. Barozzi P., Luppi M., Facchetti F., et al. Post-transplant Kaposi sarcoma from the seeding of donor derived progenitors. Nat Med 2003, 9:554-561.
96. Frances C., Mouquet C., Marcelin A.G., et al. Outcome of kidney transplant recipients with previous human herpesvirus-8 infection. Transplantation 2000, 69:1776-1779.
97. Requena L., Sangueza O.P. Cutaneous vascular proliferations. Part III. Malignant neoplasms, other cutaneous neoplasms with significant vascular component, and disorders erroneously considered as vascular neoplasms. J Am Acad Dermatol 1998, 38:143-175.
98. Feng H., Shuda M., Chang Y., Moore P.S. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science 2008, 319:1096-1100.
99. Nghiem P., Jamies N. Merkel cell carcinoma in organ transplant recipients. Skin disease in organ transplantation 2008, 190-194. Cambridge University Press, New York. C.C. Otley, T. Stasko (Eds.).
100. Penn I., First M.R. Merkel cell carcinoma in organ recipients: report of 41 cases. Transpantation 1999, 68:1717-1721.
101. Bickle K., Glass L.F., Messina J.L., Fenske N.A., Siegrist K. Merkel cell carcinoma: a clinical, histopathologic, and immunohistochemical review. Semin Cutan Med Surg 2004, 23:46-53.
102. Pulitzer M.P., Amin B.D., Busam K.J. Merkel cell carcinoma: review. Adv Anat 2009, 16:135-144.
103. Merkel cell carcinoma. AJCC Cancer Staging Manual 2009, Springer, New York, NY. 7th ed. S.B. Edge, D.R. Byrd, M.A. Carducci, C.C. Compton (Eds.).
104. Shroff R., Rees L. The posttransplant lymphoproliferative disorder-a literature review. Pediatr Nephrol 2004, 19:369-377.
105. Capaldi L., Robinson-Bostom L., Kerr P., Gohh R. Localized cutaneous posttransplant Epstein-Barr virus-associated lymphoproliferative disorder. J Am Acad Dermatol 2004, 51:778-780.
106. Taylor A.T., Marcus R., Bradley A. Posttransplant lymphoproiferative disorders after (PTLD) after solid organ transplantation. Crit Rev Oncol Hematol 2005, 56:155-167.
107. LaCasce A.S. Post-transplant lymphoproliferative disorders. Oncologist 2006, 11:674-680.